Similar articles

• Schnitzler syndrome: response to anakinra in two cases and a review of the literature.

  Schuster C, Kränke B, Aberer E, Arbab E, Sturm G, Aberer W. Schuster C, et al. Int J Dermatol. 2009 Nov;48(11):1190-4. doi: 10.1111/j.1365-4632.2009.04151.x. Int J Dermatol. 2009. PMID: 20064173 Review.
• Remission of Schnitzler syndrome after treatment with anakinra.

  Frischmeyer-Guerrerio PA, Rachamalla R, Saini SS. Frischmeyer-Guerrerio PA, et al. Ann Allergy Asthma Immunol. 2008 Jun;100(6):617-9. doi: 10.1016/S1081-1206(10)60064-6. Ann Allergy Asthma Immunol. 2008. PMID: 18592830 No abstract available.
• Schnitzler syndrome: treatment failure to rituximab but response to anakinra.

  Eiling E, Möller M, Kreiselmaier I, Brasch J, Schwarz T. Eiling E, et al. J Am Acad Dermatol. 2007 Aug;57(2):361-4. doi: 10.1016/j.jaad.2007.03.036. Epub 2007 Apr 30. J Am Acad Dermatol. 2007. PMID: 17467852
• Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.

  Kluger N, Rivière S, Guillot B, Bessis D. Kluger N, et al. Acta Derm Venereol. 2008;88(3):287-8. doi: 10.2340/00015555-0404. Acta Derm Venereol. 2008. PMID: 18480937 No abstract available.
• Successful anakinra therapy in 2 patients with Schnitzler syndrome.

  Szturz P, Adam Z, Hájek R, Mayer J. Szturz P, et al. Onkologie. 2011;34(5):265-8. doi: 10.1159/000327816. Epub 2011 Apr 26. Onkologie. 2011. PMID: 21577034 Review. No abstract available.